Thrombosis
News
Novel Watchman device approved as warfarin alternative in atrial fib
Conference Coverage
Long-term DAPT offers ongoing post-MI benefit
Key clinical point: Myocardial infarction patients 1-3 years out from their event who took long-term dual-antiplatelet therapy with aspirin and...
Conference Coverage
VIDEO: Growing evidence supports prolonged DAPT for ACS
News
Genetic blood profiles can estimate risk levels of VTE patients
News
Esophagogastric cancer patients on chemotherapy more likely to develop VTE
News
Dabigatran response in children’s blood is consistent through age groups
News
DVT, PE costs stabilize after third day of hospitalization
News
Rivaroxaban and enoxaparin had comparable rates for VTE prophylaxis after hip and knee surgery
Conference Coverage
Increase enoxaparin doses to prevent VTEs in trauma patients
Key clinical point: Enoxaparin at 30 mg twice daily isn’t adequate for preventing VTEs in trauma patients.